Lilly Endowment Inc sold $203M of LLY
owner at ELI LILLY & Co. 225,000 shares at an average of $903.07, traded Feb 25, 2025, filed Feb 26, 2025.
Score components
- +12Role10% owner
- +25Trade size$203.2M at market
- 0Share of holdings soldSold 0.2% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-005670, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 25, 2025 | SOpen-market sale Common Stock | -35,578 | $900.50 | $32M | 96,426,400 | Feb 26, 2025 |
| Feb 25, 2025 | SOpen-market sale Common Stock | -50,118 | $901.57 | $45M | 96,376,282 | Feb 26, 2025 |
| Feb 25, 2025 | SOpen-market sale Common Stock | -47,905 | $902.49 | $43M | 96,328,377 | Feb 26, 2025 |
| Feb 25, 2025 | SOpen-market sale Common Stock | -36,219 | $903.48 | $33M | 96,292,158 | Feb 26, 2025 |
| Feb 25, 2025 | SOpen-market sale Common Stock | -18,159 | $904.54 | $16M | 96,273,999 | Feb 26, 2025 |
| Feb 25, 2025 | SOpen-market sale Common Stock | -11,143 | $905.41 | $10M | 96,262,856 | Feb 26, 2025 |
| Feb 25, 2025 | SOpen-market sale Common Stock | -8,559 | $906.46 | $7.8M | 96,254,297 | Feb 26, 2025 |
| Feb 25, 2025 | SOpen-market sale Common Stock | -4,962 | $907.29 | $4.5M | 96,249,335 | Feb 26, 2025 |
| Feb 25, 2025 | SOpen-market sale Common Stock | -5,191 | $908.29 | $4.7M | 96,244,144 | Feb 26, 2025 |
| Feb 25, 2025 | SOpen-market sale Common Stock | -3,290 | $909.38 | $3.0M | 96,240,854 | Feb 26, 2025 |
| Feb 25, 2025 | SOpen-market sale Common Stock | -3,606 | $910.53 | $3.3M | 96,237,248 | Feb 26, 2025 |
| Feb 25, 2025 | SOpen-market sale Common Stock | -270 | $911.55 | $246k | 96,236,978 | Feb 26, 2025 |
Related signals
Other insiders at ELI LILLY & Co and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 37Weak | LLYsell ELI LILLY & Co | Lilly Endowment Inc owner | $18M 23,665 shares | -0% | |
| 37Weak | LLYsell ELI LILLY & Co | Lilly Endowment Inc owner | $82M 106,626 shares | -0% | |
| 21Weak | ELI LILLY & Co | Donald A Zakrowski SVP, Finance, & CAO | $735k 1,000 shares | -21% | |
| 62Notable | ELI LILLY & Co | Lucas Montarce EVP & CFO | $495k 715 shares | +5% | |
| 70Notable | ELI LILLY & Co | Ralph Alvarez director | $500k 758 shares | - | |
| 67Notable | ELI LILLY & Co | Jacob Van Naarden EVP & Pres., Lilly Oncology | $647k 1,000 shares | +5% | |
| 17Weak | ELI LILLY & Co | Ilya Yuffa EVP&Pres, LLY USA&Global Capab | $784k 1,250 shares | -5% | |
| 73Notable | ELI LILLY & Co | J Erik Fyrwald director | $1.0M 1,565 shares | +2% | |
| 56Moderate | ELI LILLY & Co | Gabrielle Sulzberger director | $75k 117 shares | +5% | |
| 63Notable | ELI LILLY & Co | Daniel Skovronsky EVP, CSO & Pres. LRL & LLY Imm | $634k 1,000 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.